Skip to content
Screener

Scansource SCSC Contingent consideration fair value adjustment

Contingent consideration fair value adjustment at other companies

Insmed logo
InsmedINSM
-$46.96M-357%
Blackrock logo
BlackrockBLK
$180M+2,100%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
-$622K—
Lifetime Brands logo
Lifetime BrandsLCUT
$0—
Lifetime Brands logo
Lifetime BrandsLCUT
$0—
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$0—

Segments

By segment

See full
Specialty Technology Solutions$410K+336%
Intelisys & Advisory$30K-96.3%

Other financials

Income statement

See full
Revenue$766.8M+8.8%
Gross profit$107.1M+6.9%
Operating income$23.1M+3.5%
Net income$16.9M-3.1%
EPS (diluted)$0.78+5.4%

Balance sheet

See full
Cash & equivalents$120.3M-17.8%
Total debt$115.5M-26.8%
Total equity$906.3M+0.5%
Total assets$1.8B+4.7%

Cash flow

See full
Operating cash flow$71.4M+8.0%
CapEx$2.4M+68.9%
Free cash flow$69.0M+6.7%

Valuation

See full
Market cap$1.12B+18.9%
Enterprise value$1.11B+14.9%
P/E15.2×+2.1×
P/S0.4×+0.1×

Profitability

See full
Gross margin13.7%+0.2pp
Operating margin3%+0.3pp
Net margin2.4%+0.1pp
FCF margin4%-1.4pp

Returns & leverage

See full
Return on equity8.1%+0.8pp
Debt / equity0.1×0.0×
Current ratio1.9×-0.2×